Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease
RecruitingNCT07324161Phase: NAStarted 2025-04-16
Summary
This study is grounded in the regulatory mechanisms of the glymphatic system and applies repetitive transcranial magnetic stimulation (rTMS) to the treatment of Alzheimer's disease (AD). The clinical
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
90 Years
Locations
rTMSFuzhou, Fujian, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07324161